In The Conversation, Drs. Golde and DeKosky explain the new test, which shows high accuracy in detecting chemicals specific to Alzheimer’s.
Renovations to the MBI’s ground floor provide investigators access to the most up-to-date state-of-the-art facilities.
Dr. Cara Croft awarded prestigious five-year fellowship supporting a collaborative UF-University College London project.
Boosted by matching funds from the MBI, the Brooks/Hagood scholarship supports young neuroscientists at UF.
In the journal Neuron, Dr. Golde highlights the promise and challenges of a possible path to treat Alzheimer’s disease and other neurodegenerative disorders.
A team led by Cara Croft, Ph.D., has demonstrated a novel method to model Alzheimer’s disease and Parkinson’s disease pathologies and seek potential therapeutic targets. Learn more:
In the journal Science, MBI leaders Drs. Steven DeKosky and Todd Golde discuss the challenges of developing effective Alzheimer's therapies and the road ahead.
MBI and 1Florida ADRC Director Todd Golde, M.D., Ph.D., shines light on UF’s role in a nationwide initiative to combat the disease and his hopes for the future
Following Sandra Day O'Connor's announcement of her dementia, and possibly Alzheimer's, diagnosis, Dr. Todd Golde explains a dementia diagnosis, current treatments and his hope for the future.
Todd Golde, M.D., Ph.D., and colleagues from Johns Hopkins and Harvard universities published a review in Nature Neuroscience highlighting the usefulness and limitations of using mouse models to study neurodegenerative diseases.